CAR-NKT cell therapy shows promising results against neuroblastoma in phase 1 clinical trial
Researchers at Baylor College of Medicine/Texas Children's Cancer Center and collaborating institutions report interim results from a first-in-human phase 1 clinical trial evaluating the safety, antitumor activity and immunological ...
May 15, 2023
0
70